WallStreetZenWallStreetZen

NASDAQ: DVAX
Dynavax Technologies Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Dynavax Technologies revenue was $277.25M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $72.0M, down 10.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DVAX annual revenue was $277.2M, with 19.4% growth year-over-year.

DVAX past revenue growth

How has DVAX's revenue growth performed historically?

Company
19.36%
Industry
10.38%
Market
20.68%
DVAX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DVAX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DVAX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DVAX revenue history

Current Revenue
$277.2M
Current Earnings
$27.3M
Current Profit Margin
9.9%

Be the first to know when DVAX announces revenue.

DVAX Revenue History By Year

DVAX Yearly RevenueDVAX RevenueDVAX ChangeDVAX Revenue Growth
2024-12-31$277.25M$44.96M+19.36%
2023-12-31$232.28M-$490.40M-67.86%
2022-12-31$722.68M$283.24M+64.45%
2021-12-31$439.44M$392.89M+844.00%
2020-12-31$46.55M$11.33M+32.18%
2019-12-31$35.22M$27.02M+329.60%
2018-12-31$8.20M$7.87M+2,407.03%
2017-12-31$327.00k-$10.72M-97.04%
2016-12-31$11.04M$6.99M+172.67%
2015-12-31$4.05M-$6.98M-63.29%
2014-12-31$11.03M-$219.00k-1.95%
2013-12-31$11.25M$1.54M+15.82%
2012-12-31$9.71M-$11.90M-55.06%
2011-12-31$21.61M-$2.34M-9.75%
2010-12-31$23.95M-$16.37M-40.60%
2009-12-31$40.32M$3.22M+8.69%
2008-12-31$37.09M$23.00M+163.21%
2007-12-31$14.09M$9.25M+190.76%
2006-12-31$4.85M-$9.81M-66.93%
2005-12-31$14.66M-$157.00k-1.06%
2004-12-31$14.81M$13.99M+1,693.22%
2003-12-31$826.00k-$601.00k-42.12%
2002-12-31$1.43M-$932.00k-39.51%
2001-12-21$2.36M$305.00k+14.85%
2000-12-31$2.05MN/AN/A

1 of 2

Dynavax Technologies Revenue FAQ

What was DVAX's revenue last quarter?

On Invalid Date, Dynavax Technologies (NASDAQ: DVAX) reported Q4 2024 revenue of $72.03 million up 29.56% year over year. In the same quarter last year, Dynavax Technologies's revenue was $55.60 million.

What was Dynavax Technologies's revenue in 2024?

Dynavax Technologies's annual revenue for the twelve months ending Dec 31, 2024 was $277.25 million, a 19.36% increase year over year.

How much does Dynavax Technologies make in a day?

Based on Dynavax Technologies annual revenue for the past five years, DVAX makes an average of $941,482.74 per day.

What was Dynavax Technologies's annual revenue growth in the past year?

As of Q2 2025, Dynavax Technologies's revenue has grown 19.36% year over year. This is 8.98 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.38%. Dynavax Technologies's revenue in the past year totaled $277.25 million.

How much does Dynavax Technologies make in a year?

Dynavax Technologies's revenue by year for the past five years is:
  • Dynavax Technologies's revenue for the twelve months ending Dec 31, 2024 was $277.25 million, a 19.36% increase year over year.
  • Dynavax Technologies's annual revenue for Dec 31, 2023 was $232.28 million, a 67.86% decrease from 2022.
  • Dynavax Technologies's annual revenue for 2022 was $722.68 million, a 64.45% increase from 2021.
  • Dynavax Technologies's annual revenue for 2021 was $439.44 million, a 844% increase from 2020.
  • Dynavax Technologies's annual revenue for 2020 was $46.55 million, a 32.18% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.